Vitalograph consolidates North American operations following US sales growth
Respiratory diagnostic firm Vitalograph has rebranded Morgan Scientific to its own name following a near doubling of US pulmonary function testing sales since 2024.
Vitalograph has officially integrated its North American subsidiary, Morgan Scientific, into its primary global brand identity. The move follows a period of significant growth for the company, which reported that its pulmonary function testing (PFT) sales in the United States have nearly doubled since 2024.
This consolidation centralizes the company's regional operations under the Vitalograph banner, aiming to streamline its market presence in respiratory diagnostics. By aligning its US business with its Ireland-based parent company, Vitalograph intends to standardize its service delivery and product distribution across its clinical and research portfolios.
The rebranding reflects broader efforts to unify global operations in an increasingly competitive diagnostic testing sector. The company maintains that this structural change will improve operational efficiency for its North American clients, including healthcare facilities and research organizations involved in clinical trials.